Close Menu

NEW YORK (GenomeWeb News) – Accelrys today reported that revenue for its second fiscal quarter decreased by 1 percent to $20 million from $20.1 million in the prior-year period.

For the three months ended Sept. 30, the company's net income climbed 50 percent to $1.8 million, or $0.07 per diluted share, from $1.2 million, or $0.04 per diluted share, for the same quarter of the previous year.

Second-quarter product development costs decreased 5 percent to $3.6 million from $3.8 million year-over-year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Apr
09
Sponsored by
Sophia Genetics

This webinar will present the utility of a personalized in silico analytical approach for the routine clinical diagnosis of channelopathies and cardiomyopathies.